Cargando…

Editorial: Sphingolipid metabolism and cancer

Detalles Bibliográficos
Autores principales:	Ivanova, Margarita M., Agoulnik, Irina U., LLeonart, Matilde E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671628/ https://www.ncbi.nlm.nih.gov/pubmed/36408170 http://dx.doi.org/10.3389/fonc.2022.1049494

Ejemplares similares

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021)

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021)

Editorial: Sphingolipid metabolism dysfunction in cancer
por: El Ridi, Rashika, et al.
Publicado: (2023)

Regulation of PP2A by Sphingolipid Metabolism and Signaling
por: Oaks, Joshua, et al.
Publicado: (2015)

Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases
por: Ivanova, Margarita
Publicado: (2020)

Editorial: Phospholipids and sphingolipids in nutrition, metabolism, and health
por: Lordan, Ronan, et al.
Publicado: (2023)

Tumor Profiling at the Service of Cancer Therapy
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2021)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

Autophagy Takes Center Stage as a Possible Cancer Hallmark
por: Alvarez-Meythaler, Jose G., et al.
Publicado: (2020)

Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
por: Benavente, Sergi, et al.
Publicado: (2020)

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
por: Li, Run-Ze, et al.
Publicado: (2022)

Editorial: Sphingolipids in Infection Control
por: Seibel, Jürgen, et al.
Publicado: (2021)

Editorial: Metabolic Plasticity of Cancer
por: Rodríguez-Enríquez, Sara, et al.
Publicado: (2020)

Editorial: Reviews in cancer metabolism
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2023)

Editorial: Redox and Metabolic Circuits in Cancer
por: Rizza, Salvatore, et al.
Publicado: (2018)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
por: Quinville, Brianna M., et al.
Publicado: (2021)

Editorial: Bioactive sphingolipids in health and disease
por: Aslan, Mutay, et al.
Publicado: (2022)

Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer
por: Giacomini, Isabella, et al.
Publicado: (2022)

Editorial: Metabolic regulation under oxidative stress in cancer
por: Subramani, Elavarasan, et al.
Publicado: (2023)

Colon Cancer and Perturbations of the Sphingolipid Metabolism
por: Machala, Miroslav, et al.
Publicado: (2019)

Editorial: Women in cancer metabolism: 2021/2022
por: Kaambre, Tuuli
Publicado: (2022)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Editorial: Cancer Metabolism: Current Knowledge and Perspectives
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2019)

Editorial: The Role of lncRNA in Cancer Metabolism
por: Huang, Guo-Liang, et al.
Publicado: (2021)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Editorial: Rising stars in cancer metabolism 2022
por: Izquierdo-Garcia, Jose Luis, et al.
Publicado: (2023)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
por: Petrusca, Daniela N., et al.
Publicado: (2022)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Sphingolipid metabolism and drug resistance in ovarian cancer
por: Kreitzburg, Kelly M., et al.
Publicado: (2018)

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022)

Editorial: Redox Potential and Metabolic Behavior in Gastrointestinal Cancers
por: Biagioni, Alessio, et al.
Publicado: (2022)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: Single cell meets metabolism and cancer biology
por: Wang, Jieqiong, et al.
Publicado: (2023)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Editorial: Pathophysiological Interrelationship Between Obesity, Metabolic Diseases, and Cancer
por: Gahete, Manuel D., et al.
Publicado: (2021)

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
por: Bapiro, Tashinga E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1vlen0h4jnct7q5li9ehljk4t2